A patient who recently underwent percutaneous coronary intervention (PCI) for an inferior wall myocardial infarction develops signs of pulmonary congestion, including crackles at the lung bases and dyspnea. Which nursing intervention is the priority to address the patient's current symptoms?

A) Administer the prescribed diuretic therapy to reduce fluid overload.

B) Encourage the patient to perform deep breathing exercises to improve oxygenation.

C) Position the patient in a supine position to promote rest and reduce cardiac workload.

D) Restrict oral fluid intake to decrease circulating blood volume.

A patient with a recent inferior wall myocardial infarction and a history of hypertension and diabetes is developing pulmonary congestion post-PCI. Which nursing intervention is most appropriate to address the patient's current symptoms and prevent further complications?

B) Position the patient in a semi-Fowler's position and administer prescribed diuretics

A) Increase the rate of intravenous fluids to maintain blood pressure

B) Position the patient in a semi-Fowler's position and administer prescribed diuretics

C) Encourage the patient to ambulate to improve circulation and prevent deep vein thrombosis

D) Withhold oxygen therapy to prevent oxygen toxicity

A patient with heart failure and pulmonary edema is being treated with intravenous furosemide and an ACE inhibitor. Which assessment finding would indicate that the treatment is effective?

C) Oxygen saturation of 92% on room air

A) Blood pressure of 180/100 mmHg

B) Heart rate of 130 beats per minute

C) Oxygen saturation of 92% on room air

D) Increased presence of crackles upon lung auscultation

A patient with newly diagnosed heart failure is being managed with intravenous furosemide and an ACE inhibitor. Which assessment finding should the nurse prioritize for immediate intervention?

B) Serum potassium level of 3.0 mEq/L

A) Blood pressure of 130/80 mmHg

B) Serum potassium level of 3.0 mEq/L

C) Heart rate of 78 beats per minute

D) Respiratory rate of 20 breaths per minute

A patient with heart failure is experiencing acute kidney injury, as evidenced by rising serum creatinine and reduced urine output. The healthcare team has adjusted the diuretic therapy by lowering the dose of furosemide and adding a thiazide diuretic. Which nursing intervention is most appropriate to monitor the effectiveness of this treatment change?

A) Measure daily weights and monitor intake and output

B) Administer additional doses of furosemide as needed

C) Increase dietary potassium intake to offset diuretic effects

D) Encourage the patient to increase fluid intake to improve renal perfusion

A patient with heart failure is experiencing hypokalemia due to the combined use of furosemide and thiazide diuretics. Which intervention should the nurse prioritize to address the patient's current condition and prevent potential complications?

B) Administer prescribed potassium supplements and monitor serum potassium levels.

A) Increase the dosage of furosemide to improve fluid removal.

B) Administer prescribed potassium supplements and monitor serum potassium levels.

C) Encourage the patient to increase dietary sodium intake to balance electrolytes.

D) Discontinue all diuretics to prevent further electrolyte imbalance.

A patient with a history of heart failure is experiencing hypokalemia as a side effect of furosemide and thiazide diuretics. The healthcare team has initiated potassium supplementation. What additional nursing intervention is most appropriate to prevent further complications related to hypokalemia?

B) Monitor the patient's cardiac rhythm for any signs of arrhythmias.

A) Encourage the patient to increase fluid intake to flush out excess diuretics.

B) Monitor the patient's cardiac rhythm for any signs of arrhythmias.

C) Advise the patient to limit dietary potassium intake to prevent hyperkalemia.

D) Discontinue all diuretic medications immediately to prevent further electrolyte imbalance.

A patient with hypokalemia is being treated with oral potassium supplements. Despite an improvement in serum potassium levels, the patient develops symptoms suggestive of worsening heart failure. Which nursing intervention should be prioritized to prevent further complications in this patient?

B) Initiate continuous cardiac monitoring to detect arrhythmias early

A) Increase the oral potassium dose to prevent hypokalemia recurrence

B) Initiate continuous cardiac monitoring to detect arrhythmias early

C) Administer additional diuretics to control fluid overload

D) Elevate the head of the bed to improve respiratory effort

A patient with hypokalemia and heart failure is being monitored after receiving oral potassium supplementation. His serum potassium is now 3.5 mEq/L. He reports fatigue and dizziness, with assessment findings of irregular heart rhythm, jugular venous distension, and an S3 heart sound. Which intervention should the nurse prioritize to address the patient's current clinical condition?

D) Administer a potassium-sparing diuretic to balance electrolytes and reduce fluid overload.

A) Administer additional oral potassium supplements to further correct hypokalemia.

B) Initiate a low-dose beta-blocker to stabilize heart rate and improve cardiac output.

C) Implement fluid restriction to manage pulmonary congestion.

D) Administer a potassium-sparing diuretic to balance electrolytes and reduce fluid overload.

myocardial infarction - Nursing Case Study

Pathophysiology

• Primary mechanism: Myocardial infarction occurs primarily due to the rupture of an atherosclerotic plaque in a coronary artery, leading to the formation of a thrombus that obstructs blood flow. This occlusion deprives cardiac tissue of oxygen and nutrients, resulting in ischemia and subsequent necrosis of heart muscle.

• Secondary mechanism: In response to ischemia, there is an imbalance in myocardial oxygen supply and demand, exacerbated by stress-induced catecholamine release, which increases heart rate and contractility, further straining the compromised heart muscle.

• Key complication: If not promptly resolved, myocardial infarction can lead to ventricular remodeling and heart failure, as the damaged cardiac tissue is replaced by non-contractile scar tissue, impairing the heart's ability to pump effectively.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: No known drug allergies

Current Presentation:

• Chief complaint: Chest pain radiating to the left arm

• Key symptoms: Shortness of breath, nausea, diaphoresis, dizziness

• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 90% on room air

Section 1

As the medical team continues to monitor the patient's condition, further diagnostic tests are performed to assess the extent of myocardial damage and any developing complications. The initial electrocardiogram (ECG) reveals ST-segment elevation in the inferior leads, suggestive of an inferior wall myocardial infarction. Additionally, serial troponin levels show a significant elevation, confirming myocardial injury. Given the patient's history of hypertension and diabetes, there is heightened concern for potential complications such as arrhythmias or heart failure.

In response to the ECG findings, the patient undergoes a coronary angiogram, which identifies a significant occlusion in the right coronary artery. To restore blood flow, the patient is taken for percutaneous coronary intervention (PCI), where a stent is successfully placed in the occluded artery. Post-procedure, the patient's chest pain subsides, and he is closely monitored in the cardiac care unit. Despite the initial success of the intervention, the patient's clinical status requires careful observation due to the risk of further complications.

In the hours following the PCI, a new complication arises: the patient develops signs of pulmonary congestion, evidenced by crackles upon auscultation of the lung bases and increasing dyspnea. His oxygen saturation drops to 85% on room air, necessitating supplemental oxygen therapy. The development of pulmonary congestion suggests early heart failure, likely due to the stress on the heart from the infarction and the pre-existing conditions of hypertension and diabetes. This change in status prompts the medical team to initiate diuretic therapy and adjust the patient's medication regimen to optimize cardiac function and prevent further decompensation.

Section 2

As the medical team continues to monitor the patient, further diagnostic evaluations are performed to assess the patient's developing condition. A repeat echocardiogram reveals a reduced ejection fraction of 40%, indicating impaired left ventricular function consistent with heart failure. Laboratory tests show rising B-type natriuretic peptide (BNP) levels, further supporting the diagnosis of heart failure. Additionally, a chest X-ray confirms pulmonary edema with bilateral infiltrates. The patient's blood pressure is noted to be elevated at 160/95 mmHg, and his heart rate is tachycardic at 110 beats per minute. These findings suggest that, despite the successful PCI, the heart is experiencing increased workload and reduced efficiency.

In response to these developments, the healthcare team decides to intensify the management plan. The patient is started on intravenous furosemide to address fluid overload, and his antihypertensive regimen is adjusted to include an ACE inhibitor to help reduce afterload and improve cardiac output. The patient is placed on continuous observation for any signs of arrhythmias, given his increased risk due to both the myocardial infarction and electrolyte shifts secondary to diuretic therapy. Close monitoring of renal function is also initiated to prevent any potential nephrotoxic effects from the aggressive diuretic use.

As the patient begins to respond to the interventions, his respiratory status shows gradual improvement, with oxygen saturation levels increasing to 92% on supplemental oxygen. Auscultation of the lungs reveals a decrease in crackles, indicating a reduction in pulmonary congestion. However, the team remains vigilant, aware that the patient’s complex medical history could predispose him to further complications. The next step in the patient's journey will focus on fine-tuning his pharmacological regimen to balance fluid status, optimize cardiac function, and prevent additional complications as he transitions to a more stable condition.

Section 3

As the patient continues under close observation, a new complication arises. Despite initial improvements in respiratory status, the patient begins to exhibit signs of renal impairment. Laboratory results reveal a rising serum creatinine level, now at 2.0 mg/dL, up from a baseline of 1.2 mg/dL, indicating a potential acute kidney injury. Urine output has decreased to less than 30 mL/hour, raising concerns about the effects of both the heart failure and the intensified diuretic therapy on renal perfusion.

Clinically, the patient appears more lethargic, and his skin shows signs of decreased perfusion, with cool extremities. Blood pressure has dropped to 105/70 mmHg, suggesting a possible overcorrection of fluid status or an adverse effect of the ACE inhibitor, which was recently initiated. The medical team recognizes the need to strike a careful balance between managing heart failure symptoms and preserving renal function.

In response to these developments, the healthcare team adjusts the diuretic regimen, opting for a lower dose of furosemide while introducing a thiazide diuretic to maintain diuresis with less renal stress. The ACE inhibitor dose is also reassessed, and the patient is closely monitored for any further changes in renal function and hemodynamic status. This nuanced adjustment aims to stabilize the patient's condition, prevent further renal compromise, and support ongoing cardiac recovery, highlighting the importance of continuous reassessment and individualized care plans.

Section 4

As the healthcare team closely monitors the patient's response to the adjusted therapeutic regimen, they note a change in his status indicating a further complication. Over the next 24 hours, the patient begins to exhibit signs of electrolyte imbalance, likely due to the modified diuretic therapy. Laboratory results reveal a serum potassium level that has dropped to 3.0 mEq/L, down from 4.1 mEq/L, suggesting hypokalemia, a common side effect of the combined use of furosemide and thiazide diuretics. Clinically, the patient reports muscle weakness and occasional palpitations, symptoms that are consistent with low potassium levels.

Additionally, the patient's blood pressure shows further instability, with readings fluctuating between 95/65 mmHg and 110/75 mmHg, raising concerns about his cardiovascular stability. The team recognizes the critical need to address the hypokalemia promptly to prevent arrhythmic complications and ensure effective cardiac function. They initiate potassium supplementation and consider adjusting the diuretic regimen further to mitigate potassium loss, possibly incorporating a potassium-sparing diuretic if necessary.

This development underscores the intricate balance required in managing the patient's complex condition, where interventions for heart failure must be carefully coordinated with renal protection and electrolyte management. The healthcare team remains vigilant, employing continuous monitoring to detect and address any further complications promptly. This approach highlights the dynamic nature of patient care, where clinical reasoning and timely intervention are pivotal in navigating the challenges of myocardial infarction management with concurrent renal and electrolyte concerns.

Section 5

As the healthcare team continues to address the patient's hypokalemia, they implement an initial intervention of oral potassium supplementation and closely monitor his response. Over the next twelve hours, his serum potassium level begins to rise, reaching 3.5 mEq/L. However, the patient's clinical presentation reveals concerning new developments. He reports a persistent feeling of fatigue and increased episodes of dizziness when attempting to sit up or mobilize, suggesting possible orthostatic hypotension. Upon assessment, his heart rate is noted to be irregular, with an average of 90 beats per minute, and an ECG shows occasional premature ventricular contractions (PVCs), which could be linked to the ongoing electrolyte imbalance and fluctuating blood pressure.

In light of these findings, the team performs a comprehensive cardiovascular assessment. They observe jugular venous distension, and auscultation reveals a new S3 heart sound, indicating a potential exacerbation of heart failure. The patient's respiratory rate is slightly elevated at 22 breaths per minute, with mild crackles noted in the lung bases, suggesting pulmonary congestion. These signs prompt the team to suspect that the patient's cardiac function is deteriorating, despite the initial stabilization efforts.

Recognizing the complexity of the situation, the healthcare team decides to refine their management strategy. They discuss the possibility of incorporating a potassium-sparing diuretic to help maintain electrolyte balance while minimizing fluid overload. Additionally, they consider introducing a low-dose beta-blocker to help stabilize heart rate and improve cardiac output. The team's priority is to achieve a delicate balance between addressing the patient's electrolyte disturbances, managing his heart failure symptoms, and ensuring hemodynamic stability, all while preventing further complications. This adaptive approach underscores the importance of continuous clinical reasoning and vigilant monitoring to guide the patient's recovery journey.